startups technology enabled weight loss services glp-1 Matthew Gallagher founded Medvi, a telehealth platform for Unlocking Patient Support Potential with

Products Welcome to our peptide shop the complete destination for researchers, laboratories, and R&D teams looking for pharmaceutical-grade products (research peptides)

Coverage requires provider approval, prior authorization, and CMS eligibility rules

Your healthcare provider can help you understand what to expect from your medication

Dual agonism of GIP and GLP-1 produced superior glycemic control and body weight reduction compared to GLP-1 receptor agonism alone (Frias, New England Journal of Medicine )

Severe cramps warrant a dose pause (12 weeks) to stabilize electrolytes, possible dose reduction, or slower titration

Irregular intervals muddy the picture and can lead to premature escalation or unnecessary delays